Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The new criteria for classifying lupus are more accurate and comprehensive.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Prednisolone and Bactrim improved symptoms in a woman with Cronkhite-Canada syndrome.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

Social media can help compare the effectiveness and safety of new arthritis medications.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

A patient's grey hair regained color during treatment with adalimumab.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.